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The role of ICOS in the development of CD4 T cell help
and the reactivation of memory T cells
Simmi Mahajan*1, Ana Cervera*1,2, Megan MacLeod**1, Simon Fillatreau***1,
Georgia Perona-Wright1, Stephen Meek3, Andrew Smith3, Andrew MacDonald1 and David Gray1
1 Institute of Immunology and Infection Research, University of Edinburgh, Ashworth Laboratories,
King's Buildings, Edinburgh, UK
2 Unidad Mixta de Investigacin Centro Nacional de Investigaciones Cardiovasculares Carlos III –
Universitat de Valencia, Valencia, Spain
3 Institute of Stem Cell Research, University of Edinburgh, King's Buildings, Edinburgh, UK
We have addressed the role of the inducible costimulator (ICOS) in the development of
T cell help for B cells and in the generation, survival and reactivation of memory
CD4 Tcells and B cells. We find that while Tcell help for all antibody isotypes (including
IgG2c) is impaired in ICOS knockout (ICOS-KO) mice, the IFN-c response is little
affected, indicating a defect in helper function that is unrelated to cytokine production.
In addition, the ICOS-negative T cells do not accumulate in B cell follicles. Secondary
(memory), but not primary, clonal proliferation of antigen-specific B cells is impaired in
ICOS-KO mice, as is the generation of secondary antibody-secreting cells. Analysis of
endogenous CD4 memory cells in ICOS-KO mice, using MHC class II tetramers, reveals
normal primary clonal expansion, formation of memory clones and long-term (10 wk)
survival of memory cells, but defective expansion upon reactivation in vivo. The data
point to a role of ICOS in supporting secondary, memory and effector T cell responses,
possibly by influencing cell survival. The data also highlight differences in ICOS
dependency of endogenous T cell proliferation in vivo compared to that of adoptively
transferred TCR-transgenic T cells.
Supporting information for this article is available at
http://www.wiley-vch.de/contents/jc_2040/2007/36661_s.pdf
Introduction
Inducible costimulator (ICOS) is a costimulatory
molecule in the CD28 family, whose expression is
induced during the activation of CD4 Tcells [1, 2]. Most
notably, it is expressed on the Tcell subset found in B cell
follicles [1]. It is also associated with the production of
IL-10 by T cells [1]. ICOS ligand (ICOSL), also known as
B7RP-1 [3], B7-H2 [4], or B7h [5–7], is expressed on
resting B cells, dendritic cells (DC) and activated
monocytes. Genetic deletion of ICOS in mice has
clarified some of the issues concerning ICOS function,
while confusing others [8–10]. For instance, it became
clear that in the absence of ICOS the T-dependent B cell
response was impaired such that development of
germinal centers was minimal [11] and the secretion
of switched isotype antibody responses following
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immunization was defective. Initially, the defect in the
production of cytokines by T cells in the knockout mice
was shown to be in the Th2 arm of the response (e.g.
reduced IL-4), as well as a lack of IL-10, while IFN-c was
relatively unaffected and in some cases increased
[8–10]. It was surmised that ICOS costimulated for
the differentiation of Th2 cells. Subsequently, the Th2
bias has come into question, with clear evidence that
ICOS costimulation is required for both Th1 and Th2
responses [12–18]. The association with the IL-10
response still holds and has strengthened, with the
development of IL-10-producing regulatory T cells in
vivo being found to be ICOS dependent [19, 20].
The confusing picture with respect to the role of ICOS
in cytokine responses may be related to the assays used;
however, a recent paper by Lhning et al. [21] offers an
attractive explanation. First, these authors showed
clearly that ICOS is expressed by effector T cells of all
types, irrespective of the cytokine they secrete. However,
importantly, they also show that the level of ICOS
expression is correlated with the cytokines produced;
thus, T cells expressing high levels of ICOS made IL-10,
intermediate ICOS expressors made Th2 cytokines,
while those expressing only low amounts made
cytokines such as IL-2, IFN-c or GM-CSF.
Other contradictions also exist, for instance, some
authors have found that the migration of T cells into
B cell follicles is independent of ICOS [15], while others
find that the development of the follicular helper TFH
population requires ICOS [22]. More fundamentally, the
role of ICOS in primary clonal expansion of CD4 Tcells is
still contentious. Most initial studies, using in vitro
stimulation, showed little effect of ICOS blockade or
absence. However, more recently, Smith et al. [15] have
shown that primary antigen-driven clonal expansion of
adoptively transferred TCR-transgenic T cells is suscep-
tible to ICOS blockade. In contrast to the primary
response, the role of ICOS in the restimulation and
clonal expansion of memory B and T cells during
secondary responses has received relatively little atten-
tion. To address this, we tracked the antigen-specific B
and T cell responses in ICOS-deficient mice using
fluorescent antigen, phycoerythrin (PE; B cells) or
MHC class II tetramers (T cells). We show that while
primary expansions are relatively independent of ICOS,
the secondary expansion is dependent on ICOS. We also
found that although primary expansion of endogenous
(polyclonal) CD4 T cells did not require ICOS, the
expansion of naive TCR-transgenic T cells after adoptive
transfer and immunization was ICOS dependent.
Results
T-dependent antibody responses are impaired in
these ICOS–/– mice
The ICOS locus was targeted with the dual aim of
inserting a reporter (b-gal) and also to knockout the
gene in mice homozygous for the deletion. Details of the
targeting strategy are provided in the Materials and
methods section and in Supporting Information Fig. 1.
Confirmation that gene targeting had abolished ICOS
expression is provided in Supporting Information Fig. 2.
ICOS–/– and ICOS+/+ mice were immunized with
haptenated protein, dinitrophenyl-keyhole limpet he-
mocyanin (DNP-KLH) i.p., and the titer of DNP-specific
immunoglobulin isotypes in the sera was measured at
days 0, 7 and 13 post immunization by ELISA. As
described earlier, a marked defect was observed in the
class-switched isotypes in the ICOS–/– mice (Fig. 1). The
anti-DNP IgG response was around 2.5-fold lower in
ICOS–/– mice at day 7 with a further reduction at day 13
when it was around 5-fold lower. A similar reduction in
titers of DNP-specific IgG1 was noticed in the sera of
ICOS–/– mice. ICOS–/– mice elicited a markedly reduced
IgG2c response both at day 7 (10-fold lower) and day 13
(20-fold lower). Reduction in the titers of IgG3 and
IgG2b was notable but less marked than for the other
isotypes. Hence, as reported in other ICOS-deficient
mice, the interaction between T and B cells via ICOS-
ICOSL is critical for B cells to produce class-switched
antibodies.
Similar to previous reports [11], the ICOS–/– mice
had fewer and smaller GC than ICOS+/+ mice
(Supporting Information Fig. 2).
Th2 cytokine production is impaired in ICOS–/–
mice
We next asked if the secretion of cytokines by CD4 Tcells
in our ICOS–/– mice correlated with the defects recorded
in immunoglobulin isotype production (Fig. 1). The
production of cytokines by T cells in response to
immunization with either schistosome egg antigen
(SEA)- or heat-killed Proprionebacterium acnes (Pa)-
pulsed DC was measured by ELISA [23, 24]. The data
(Fig. 2) are roughly in agreement with published data
[8–10], with IFN-c largely unaffected and Th2 cytokines
reduced (IL-4 and IL-5, but not IL-13, reached statistical
significance). In the context of the Th1 response, it is
interesting to note that, although IgG2c production was
dramatically impaired in the antibody response of ICOS
knockout mice (Fig. 1), there was no impact of the
absence of ICOS on the production of IFN-c that drives
switching to this isotype. Interestingly, the IL-10
response was not reduced as dramatically as expected
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from previous data. We found that IL-17 was produced
only in response to Pa, and although less was made in
the restimulation of ICOS–/– T cells, this was not
statistically significant.
ICOS is important for the development of T cell
help for B cells
The above data suggest that abnormal cytokine secretion
is not the basis of the defect in the T-dependent antibody
response. To investigate the development of Tcell helper
function in ICOS–/– mice, we utilized a hapten carrier-
based in vitro help assay, addressing whether ICOS-
deficient T cells can support the production of class-
switched antibodies by wild-type B cells. B cells from
DNP-KLH-primed C57BL/6 mice were cultured in vitro
with ovalbumin (OVA)-primed ICOS-deficient or -suffi-
cient purified CD4+ T cells in the presence of soluble
DNP-OVA. The medium containing the antigen was
removed after 2 days and replaced with fresh medium.
Culture supernatants were harvested 5 days later and
DNP-specific IgM, IgG, IgG1 and IgG2c were measured
by ELISA. As shown in Fig. 3, the IgM response was
unaffected by the absence of ICOS. However, T cells
lacking ICOS were unable to help primed B cells to class
switch. The amounts of total IgG and of IgG1 and IgG2c
were significantly lower in the supernatants of cultures
with ICOS–/– T cells as compared to the ICOS+/+ T cells.
We conclude that the ICOS-ICOSL interaction between T
and B cells is critical for the development of the T cell
helper function.
ICOS–/– CD4 T cells do not migrate into the B cell
follicles
T cells provide help to initiate GC, maintain B cell
proliferation, cause differentiation within the GC and
finally deliver long-term survival signals (via CD40) that
allow GC B cells to enter the memory pool [25]. These
events require the presence of T cells inside or close to
B cell follicles. To see if ICOS plays a role in T cell
migration, we stained the spleen sections of ICOS+/+
and ICOS–/– mice immunized 9 days earlier with DNP-
KLH for Tand B cells. As can be seen in Fig. 4A, very few
CD4 T cells enter the follicles in the ICOS–/– mice.
Quantitation revealed that the number of T cells per
Figure 1. ICOS is critical for production of all IgG subclasses. DNP-specific immunoglobulins in the sera of ICOS+/+ (open bars) and
ICOS–/– (grey bars) mice at 7 and 13 days after i.p. immunization with alum-precipitated DNP-KLH were measured by ELISA.
Antibody titers were calculated by plotting serum concentration against OD and reading the dilution at the half-maximal OD of a
positive control. Data is representative of four independent experiments and the error bars indicate the SEM of four mice per
group. The data shown here is frommice prior to extensive backcross (generation 5), but is almost identical in mice backcrossed
for ten generations to C57BL/6. ICOS+/+ mice here are littermate controls.
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follicle in ICOS+/+ mice was threefold higher than in
ICOS–/– mice (Fig. 4B). Quantitation of follicular (IgD+)
areas showed no difference in follicular size in ICOS+/+
and ICOS–/– mice.
ICOS–/– mice have fewer class-switched antibody
secreting cells
Given that there was impairment to the isotype-switched
antibody responses in ICOS–/– mice, we predicted that
the number of antibody-secreting cells (ASC) in ICOS-
deficient mice would be reduced. To confirm this and to
ask if different populations of plasma cells (i.e. splenic,
short-lived versus bone marrow, long-lived) were
differentially affected we carried out ELISPOT assays
on spleen and bone marrow cell suspensions from
immunized mice. ICOS–/– and control ICOS+/+ mice
were immunized i.p. with alum-precipitated DNP-KLH,
and the frequency of DNP-specific ASC in these tissues
was measured after 3 wk. Fig. 5 (top panels) shows that
the number of ASC producing class-switched antibodies
(IgG and IgG1) in the primary response was not
significantly different in the ICOS–/– mice in comparison
to ICOS+ mice, although the trend is toward lower
numbers. However, the number of IgM+ ASC in the
spleen as well as bone marrow was higher in ICOS–/– as
compared to control mice. Negligible numbers of class-
switched ASC were detected in wells with splenocytes
from non-immunized ICOS–/– and ICOS+/+ mice (not
shown).
To examine if ICOS is required for the secondary ASC
response, mice were boosted with DNP-KLH-alum 5 wk
after the primary immunization, and spleens and bone
marrow were harvested 5 days later. The effect of the
Figure 2. Role of ICOS in effector T cell differentiation. C57BL/6 DC were cultured overnight in medium alone (M), with SEA or Pa
and injected into wild-type and ICOS–/– mice i.p. After 7 days, spleen cell suspensions were made and cultured in medium (white
bar), with SEA (grey) or with Pa (black) for 3 days before the supernatants were harvested. The levels of cytokine production by
splenocytes were measured by ELISA. Data shown is representative of two experiments. Error bars indicate SEM of three to four
mice per group. The data shown is from generation 10 C57BL/6 backcross mice.
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absence of ICOS was much more pronounced in the
secondary response, as there was a significant reduction
in the number of ASC producing IgG and IgG1 in the
spleen. A similar trend was noticed in the bone marrow,
although the difference was not significant in relation to
IgG1. Secondary IgM-producing ASC in the spleen of
ICOS–/– mice were notably reduced as well, while this
was not apparent in the bone marrow (Fig. 5, bottom
panels). The secondary B cell responses were particu-
larly deficient in the absence of ICOS-ICOSL interac-
tions, suggesting a role in the generation or reactivation
of antigen-specific memory B cells.
Antigen-specific B cell expansion in primary and
secondary responses in ICOS–/– mice
To investigate the generation of B cell memory in the
absence of ICOS, we quantified the expansion of
antigen-specific B cells, in primary and secondary
responses, by enumerating the PE-binding, CD19+
splenic B cells in the mice 2 wk after immunization
with alum-precipitated PE. The data shown in Fig. 6 is
pooled from three independent experiments, and
although there is a trend towards lower antigen-specific
expansion in the primary response of ICOS–/– mice, this
is not statistically significant.
Mice primed with PE were rechallenged 5 wk later
and the secondary expansion of memory PE+ B cells was
evaluated 5 days after the boost. In this secondary
response there was a significant reduction in the
percentage of PE+ B cells in ICOS–/– mice as compared
to ICOS+/+ mice (Fig. 6). Thus, secondary/memory
B cell clonal expansion requires ICOS and is more
dependent than primary clonal expansion.
CD4 T cell priming in vivo using ICOS–/– TCR-
transgenic T cells
As in previous studies, we found that the primary clonal
expansion of T cells, as measured by in vivo immuniza-
tion (with KLH) followed (on days 7 and 13) by in vitro
antigenic restimulation, did not differ in ICOS–/– or
ICOS+ mice (data not shown). As this might not reflect
Figure 3. ICOS–/– T cells do not help wild-type B cells to produce
antibody. DNP-KLH-primed C57BL/6 B cells were cultured with
OVA-primed T cells from ICOS+/+ (open bars) and ICOS–/– (grey
bars) in the presence of soluble DNP-OVA. The culture
supernatant was harvested 7 days later and the amount of
DNP-specific antibodies measured by ELISA. Comparative
titers were calculated by plotting the concentration against
OD and reading the dilution at the half-maximal OD of a
positive control. The two groupswere compared statistically by
unpaired Student's t-test. *p <0.05; **p <0.01. Data shown here
is from generation 7 C57BL/6 backcross mice and is represen-
tative of three independent experiments, each using four mice
per group. The error bars indicate the SEM.
Figure 4. ICOS–/– T cells do not migrate into B cell follicles.
(A) Immunohistological stain showing T cells in B cell follicles
in ICOS+/+ and ICOS–/– mice 8 days after immunization. Note
the relative lack of green Thy-1+ T cells in the IgM+ (red) follicle
from the ICOS–/– mouse. Original magnification 400. (B) The
T cell migration was quantified by counting T cells within the
IgD+ area under the microscope. The data were plotted using a
box and whiskers representation. The box extends from the
25th to the 75th percentile, with a horizontal line at the median
(50th percentile). Whiskers extend down to the smallest value
and up to the largest. The data is a compilation of counts from
fivemice and is representative of two similar experiments. The
data shown is from generation 10 C57BL/6 backcross mice.
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the behavior of the T cells in vivo, we carried out
adoptive transfers of ICOS-deficient and ICOS-sufficient
OT-II (OVA peptide-specific, H-2b-restricted, TCR-trans-
genic) lymph node cells into naive C57BL/6 mice,
followed by i.p. immunization with alum-precipitated
OVA 24 h later. The expansion of CD4+ T cells in these
mice was followed from day 3 to day 8 post immuniza-
tion (Fig. 7). In normal mice using this adoptive transfer
system, the peak of the clonal expansion is at day 4. We
found that T cell priming in the spleen and lymph node
was significantly reduced in the absence of ICOS on
T cells. The percentage of Va2Vb5-positive CD4
+ T cells
was considerably lower at the peak of the clonal
expansion phase when transferred transgenic T cells
lacked ICOS (Fig. 7). The kinetics were slightly different
also, as the expansion that occurred in the ICOS–/– T cell
population (rising from *1.6 to 6% in the spleen)
peaked at day 3 and not day 4. At the later time point of
day 8, corresponding to the end of the contraction
phase, the ICOS+/+ T cells survived at a higher baseline
level compared to ICOS–/– T cells. The behavior of the
OT-II T cells in spleen and inguinal lymph node after
immunization was broadly similar. This result is in
agreement with the study of Smith et al. [15] using a
similar model.
CD4T cell priming in vivo in ICOS–/–mice analyzed
by MHC class II tetramers
As the study of memory CD4 T cells using the TCR-
transgenic adoptive transfer model is problematic [26,
27], we also followed the endogenous, polyclonal T cell
response in normal and ICOS-deficient mice using MHC
class II tetramers [28]. The tetramers are H-2Ab
Figure 6. Antigen-specific B cell responses in ICOS–/– mice.
Antigen (PE)-driven B cell clonal expansion during primary and
secondary response in ICOS+/+ and ICOS–/–micewasmeasured.
Splenocytes from mice (generation 10 C57BL/6 backcross)
immunized 2 wk earlier with alum-precipitated PE were
stained with anti-CD19 antibody and PE. For secondary
response, mice were boosted 5 wk later and spleens were
harvested 5 days later. PE+ cells are plotted as % of CD19+
B cells. The data shown is pooled from three independent
experiments; it has been analyzed using an unpaired t-test,
applying Welch's correction for unequal variance for the
secondary response.
Figure 5. ASC numbers are low in secondary responses in ICOS–/– mice. ELISPOTwas performed to enumerate the ASC in spleen
and bone marrow of ICOS+ (&) and ICOS–/– (*) mice immunized i.p. with alum-precipitated DNP-KLH 3 wk earlier. Mice were
boosted 5 wk after the primary immunization, and spleens and bone marrow were harvested 5 days later to measure the
secondary response. Each symbol represents the data from an individual mouse and lines show the mean of each group. Data is
representative of two independent experiments using generation 7 C57BL/6 backcross mice. The two groups were compared
statistically by unpaired Student's t-test; *p <0.05. Representative FACS plots of the secondary response are shown as Supporting
Information Fig. 3A.
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containing a peptide from the envelope protein (H19-
Env) of Moloney murine leukemia virus [29]. As a
prelude to the analysis of memory T cells, we
investigated priming of the endogenous T cell popula-
tion. ICOS–/+ and ICOS–/– mice were immunized s.c.
with H19-Env peptide in CFA and the percentage of
tetramer-positive cells was measured at days 8 and 15 in
the draining lymph nodes and the spleen. As shown in
Fig. 8, the percentage of tetramer-positive CD4 Tcells in
the spleen as well as the draining lymph nodes at day 8
was equivalent in ICOS–/– and ICOS+/+ mice. The same
was true also at day 15, although in the lymph nodes of
ICOS–/– mice, there were slightly fewer tetramer-
positive T cells (not statistically different). We conclude
that priming of endogenous CD4 T cells in vivo was not
impaired in the absence of ICOS signaling.
Restimulation of CD4 memory T cells is ICOS
dependent
Using the MHC class II tetramers, the frequency of
antigen-specific CD4 Tcells after primary expansion was
similar in ICOS–/– and ICOS+/+ mice. To test the ICOS
dependency of the memory response, we primed mice
with H19-Env peptide-pulsed DC and then rested the
mice for 10 wk prior to boosting with H19-Env peptide
in CFA. Fig. 9A shows that the survival of these antigen-
specific memory T cells for 10 wk is unimpaired by the
lack of ICOS; thus, prior to immunization, the number of
tetramer-positive cells is similar in ICOS–/– and ICOS+/+
mice.
Following recall, however, there was a significant
impairment of the expansion of the memory population
(Fig. 9B). This was particularly evident in the draining
lymph nodes and slightly less so in the spleen. So while
ICOS is dispensable for the clonal expansion of naive
T cells, the proliferation of memory CD4 T cells requires
ICOS costimulation.
Discussion
The expression of ICOS within the first 48 h after T cell
activation suggests that it may contribute to the
differentiation of T cells during the primary response.
Our data suggest that it is not required for the
proliferative response, but that it is necessary for the
development of the capacity to help B cells make
antibody. We have also addressed the role of ICOS
costimulation in B and T cell memory responses: The
generation of memory B cells and differentiation into
antibody-secreting plasma cells in the secondary
response is much more affected than the primary
response, which is relatively normal. Tracking of the
CD4 Tcell memory response withMHC class II tetramers
shows no impairment of the primary clonal expansion,
or long-term survival, but does show impaired second-
ary expansion. Our data also highlight critical differ-
ences in the response requirements of endogenous,
polyclonal T cells and adoptively transferred TCR-
transgenic T cells.
At first glance, it is tempting to associate the lack of
helper function development in ICOS–/– T cells with the
defect in cytokine production (especially Th2). How-
ever, we are not convinced that differences in cytokine
secretion by ICOS–/– T cells underlie this helper defect,
for two reasons: First, in the helper assay used here, we
are not testing whether the T cells support antibody
isotype switching, as this will already have occurred in
vivo during priming of the B cells in their ICOS-sufficient
Figure 7. ICOS-dependence of in vivo clonal expansion of TCR-transgenic T cells. C57BL/6 mice received OT-II ICOS+/+ (&) or OT-II
ICOS–/– (*) lymph node cells 24 h before immunization with OVA-alum i.p., and the expansion of Va2/Vb5
+ cells was measured at
days 3, 4, 6 and 8 in the spleen and inguinal lymph nodes. Va2/Vb5
+ cells depicted as % of CD4 cells. Both groups were statistically
compared using unpaired Student's t-test; *p <0.05; **p <0.01; ***p <0.001. The data is representative of three independent
experiments, each using four mice per group per time point. The data shown is from generation 10 C57BL/6 backcross mice.
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donor mice. Second, there is a profound lack of both
IgG1 and IgG2c (IgG2a equivalent in C57BL/6 mice),
the latter being associated with Th1 (IFN-c) responses,
which are quite normal in these mice. What is missing in
the in vitro assay seems to be the ability to support
reactivation and differentiation of the antigen-specific
memory B cells to become antibody secretors. This
conclusion is supported by the phenotype of the SAP–/–
mice [30], which have no particular defect in T cell
cytokine production but exhibit reduced IgG1 and IgG2a
humoral responses and, interestingly, display impaired
expression of ICOS.
What do ICOS-deficient T cells lack as helpers? It
could be that they fail to make a particular cytokine (e.g.
IL-10, IL-6 or, possibly, IL-21) or, possibly, they fail to
express surface molecules that provide help/survival
signals for B cells. However, ICOS–/– T cells might
themselves fail to survive as effector Tcells. For instance,
the failure of ICOS–/– T cells to populate B cell follicles
may not be due simply to a defect in migration of the
cells to the follicle, but rather a failure to survive there as
a stable population of TFH cells. It will be interesting to
see if the helper defect (and follicular colonization) can
Figure 8. Primary clonal expansion of endogenous T cells is
ICOS independent. Antigen (H19-Env peptide)-specific T cells
were enumerated using MHC class II tetramers: Tetramer-
positive cells expressed as percentage of CD4+ T cells in the
draining lymph nodes and spleens of ICOS+/+ (&), ICOS–/– (*)
and naive (&) mice 8 and 15 days after s.c. immunization with
H19-Env-CFA. Ag-specific CD4 T cells detected using IAb-H19-
Env tetramers. Each point represents an individual mouse and
the line shows themean of the group. Data is representative of
two independent experiments using generation 10 C57BL/6
backcross mice.
Figure 9. ICOS is needed for reactivation but not survival ofmemory CD4 T cells. (A) ICOS+/+ and ICOS–/–micewere immunized s.c.
with H19-Env-CFA and Ag-specific CD4 T cells detected using IAb-H19-Env tetramers 10 wk later in the draining lymph nodes and
spleen. Each point represents an individual mouse and the line shows the mean of the group. One representative of two
independent experiments is shown. (B) ICOS+/+ and ICOS–/– mice were immunized s.c. with H19-Env-pulsed, LPS-matured wild-
type DC and boosted with peptide-CFA after 10 wk. Mice were killed on day 5 after boost, and draining lymph nodes and spleens
taken for tetramer staining. Each point represents an individual mouse and the line shows the median of the group. The data
shown is representative of three independent experiments and is from generation 10 C57BL/6 backcross mice. Statistical
comparison was done by unpaired Student's t-test; *p <0.05. Representative FACS plots of the secondary response are shown as
Supporting Information Fig. 3B.
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be rescued by constitutive expression (after retroviral
transfection) of survival genes such as bcl-2 or bcl-XL. It
is worth noting that our current understanding of the
sequence of events that lead to follicular localization of
T cells does not require ICOS: CD40/CD154 interactions
up-regulate OX40L on DC leading to up-regulation of
CXCR5 (and down-regulation of CCR7) and hence
migration to follicles [31, 32]. A role in survival of
activated or effector T cells is consistent with the
utilization by ICOS of the phosphoinositol-3-kinase
(PI3K) pathway via serine/threonine kinases phosphoi-
nositide-dependent kinase 1 (PDK1) and protein
kinase B (PKB) to regulate apoptosis [33]. In this
regard, there may be convergences in both function and
signaling between ICOS and OX40, which mediates
survival of effector Tcells via the PI3K-PKB pathway [34,
35]. This scenario is supported by observations that
ICOS blockade in vivo is particularly effective when
given during the late (effector) phase of Th1/Th17-
mediated EAE [14] or Th2-mediated airway inflamma-
tion [12]. It has also been observed in less complex in
vivo models using immunization with nominal antigen
that the expansion of already differentiated Th1 or Th2
cells is considerably affected by blocking ICOS [15, 36].
Further evidence comes from studies of Th2 responses in
worm infection [37] or in lung inflammation [38, 39], in
which ICOS costimulation is needed for the inflamma-
tory response but not for the development of the
responding Th2 cells.
The blockade of ICOS in the models of inflammatory
disease discussed above [12, 14] was not effective when
given during the early priming phase, and there is
general agreement that ICOS signaling does not
significantly contribute to clonal expansion of naive
T cells. However, some experiments have indicated an
effect of early ICOS blockade [15]. These studies
analyzed the response of adoptively transferred TCR-
transgenic cells. Our own analysis of the clonal
expansion of small numbers of ICOS-deficient OT-II
TCR-transgenic cells transferred into C57BL/6 mice and
then immunized with OVA peptide in alum (or CFA) also
showed impaired proliferation. In contrast, our analysis
using MHC class II tetramers of the primary expansion
of endogenous, polyclonal CD4 Tcells revealed no defect
in ICOS knockout mice. We are left with the conclusion
that the requirements for optimal expansion of the
transferred population of TCR-transgenic cells are
different from those of the endogenous naive T cells.
The most likely explanation for this is the difference in
initial clone size. Despite transferring only a small
number (2  106) of transgenic cells, the frequency of
antigen-specific naive cells (all with the same TCR
idiotope) is at least 100-fold higher than in the
endogenous T cell population. It seems likely that
stimulatory and/or survival signals (antigen + costi-
mulation) at response initiation are normally limiting
and that to support an abnormally large initiating T cell
population requires excessive costimulation. We, and
many others, have found this TCR-transgenic transfer
system problematic with respect to studying memory:
The cells do not survive well and cannot be reactivated.
Jenkins and colleagues [27] recently showed that the
reason for this is the abnormally large clone size of
transferred cells and that, when physiologically appro-
priate numbers of TCR-transgenic CD4 T cells were
transferred, the memory clones became stable [27]. The
behavior of CD8 memory T cells also seems to be
influenced by the original clone size [40]. The results we
present here suggest caution in interpreting the data
from the TCR-transgenic adoptive transfer models even
in the primary response.
To analyze the T cell memory response in ICOS-
deficient mice, we utilized MHC class II tetramers and
followed the frequency of antigen-specific CD4 T cells
over time since primary immunization and then after
boosting. There was no difference in the ability of CD4
memory T cells to survive over a 10-wk period in ICOS-
deficient or -sufficient mice. However, secondary
expansion in ICOS–/– mice was impaired. Likewise,
the secondary expansion of memory B cells and
secondary ASC in T-dependent responses is much more
ICOS dependent than in the primary response. As
discussed above, the importance of ICOS in memory
responses may simply reflect the increased need for
costimulation when antigen-specific precursor fre-
quency is high. However, this interpretation does not
fit with the general idea that memory cell restimulation
requires less costimulation [41]. Indeed, we recently
showed that the proliferation of memory CD4 T cells in
vivo did not require CD40-CD154 interactions [28].
Thus, ICOS may well be a costimulus that is used
preferentially in memory T cell responses. Taken as a
whole, our data strongly point to roles for ICOS in
supporting effector and memory T cell responses. It will
be of future interest to see if these roles utilize a similar
mechanism or if they are mechanistically separate.
Materials and methods
Mice
ICOS–/–, C57BL/6, OT-II [42] and OT-II ICOS–/– mice were
bred and maintained under specific pathogen-free conditions
in the animal facilities of the School of Biological Sciences at
the University of Edinburgh (Edinburgh, UK). Mice were used
at 6–12 wk of age, and were sex- and age-matched within
experiments as closely as possible. All experiments were
covered by a project license granted by the Home Office under
the Animal (Scientific Procedures) Act 1986. Locally, this
license was approved by the University of Edinburgh Ethical
Review Committee.
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Generation of ICOS–/– mice
A knockout allele of the ICOS gene was generated by gene
targeting in E14Tg2a ES cells (129/Ola strain) by standard
procedures. The targeting vector replaced almost the entire
exon 2 and all of the exons 3 and 4 coding sequences with a
cassette consisting of a b-galactosidase coding sequence (lacZ)
preceded by an internal ribosome entry site (IRES) sequence
and followed by a neomycin resistance gene expressed from its
own promoter (MC1neopolyA) (Supporting Information
Fig. 1A). Male chimeras generated with ICOS-targeted ES
cells were test-crossed with C57BL/6 females and germ-line
transmission of the ICOS disruption was confirmed in the
agouti coat-colored test-cross offspring by Southern blot
analysis of Eco R1-digested DNA obtained by tail biopsy and
hybridization with probes flanking each side of the vector
integration position (Fig. 1B). Homozygous ICOS–/– mice were
generated by inter-crossing male and female test-cross
heterozygous ICOS+/– offspring. The ICOS-deficient line has
been backcrossed for ten generations to C57BL/6. Some
experiments were done on generation 5 and 7 backcross mice
(Fig. 1, 3, 5), while the backcrossing was still being carried
out, all other experiments were done on generation 10 C57BL/
6 backcross mice. The backcross generation used is indicated in
the figure legends. Control groups consisted of age/sex-
matched C57BL/6 mice.
A cautionary note needs to be added as the region on
chromosome 1 that includes the Icos gene has been identified
as a susceptibility locus for diabetes in NOD mice [43]. Even
after ten generations backcrossing to C57BL/6, there remains a
significant region around the Icos gene that derives from the
129 strain. This region exhibits a polymorphism that influences
autoimmune responses [43, 44], although there is no
indication in the literature that the 129 strain carries the
susceptible locus. Given this and the highly reproducible
nature of our results, we are confident of that the effects we
observe are the result of the ICOS deficiency.
Antigens and immunizations
PE (Prozyme), OVA (Sigma-Aldrich), and KLH (Calbiochem)
were used as protein antigens. OVA and KLH were coupled to
DNP using dinitrofluorobenzene (Sigma-Aldrich). To study B
or T cell clonal expansion, the mice were immunized with
200 lg alum-precipitated OVAor 100 lg alum-precipitated PE.
OVA was also emulsified in CFA (Sigma-Aldrich) to immunize
mice for adoptive transfer experiments. For help assays, mice
were injected either with 200 lg alum-precipitated DNP-KLH
along with 109 killed Bordetella pertussis bacteria (Lee
laboratories, Grayson, USA) or 150 lg alum-precipitated
OVA with 109 B. pertussis bacteria. Endotoxin-free SEA was
either prepared in-house [23, 45, 46] or provided by Prof. Mike
Doenhoff, University of Bangor. P. acnes, a gram-positive
bacterium, was obtained from American Type Culture Collec-
tion (no. 6919, ATCC, Manassas, VA).
For experiments using MHC class II tetramers, mice were
immunized with H19-Env (EPLTSLTPRCNTAWNRLKL) or
OVA323–339 peptide (ISQAVHAAHAEINEAGR) (both supplied
by Advanced Biotechnology Centre, Imperial College, London,
UK). The peptides were emulsified in CFA (Sigma-Aldrich) and
injected s.c., 100 lg/mouse. In some experiments, peptide-
pulsed bone marrow-derived DC were injected s.c.
Bone marrow-derived DC
For immunization with H19-Env peptide, DC were grown from
bone marrow progenitors using GM-CSF, following a protocol
based on that of Inaba et al. [47]. Bone marrow cells were
plated in 24-well tissue culture plates at 3.75  105 cells/mL
in medium supplemented with 5% GM-CSF containing
supernatant from the transfected cell line X63-GM-CSF [48].
Cells were grown for 7 days and washed on days 3 and 6, with
the FCS in the medium being replaced with 0.5%mouse serum
(Harlan). DC were harvested on day 7, incubated at 37C
together with 0.1 lg/mL LPS (Sigma-Aldrich) at
1  106 cells/mL for 12–13 h, and then reharvested. The DC
were incubated for 90 minwith 50 lg/mL peptide and washed
extensively with PBS before injection into mice.
For DC immunization in SEA/Pa experiments, DC were
generated by a modified protocol. DC were grown in the
presence of recombinant GM-CSF (Peprotech, London, UK) for
11 days, as previously described. Cells were >95% CD11c+
MHC class II+ DC. To activate the DC, cells were harvested on
day 10 of culture and replated at 2  106 DC/mL in the
presence of either SEA (50 lg/mL) or P. acnes [10 lg/mL;
both as measured by the Coomassie Plus Protein Assay (Perbio
Science UK Ltd., Cramlington, UK)] for their final 18 h of
incubation.
CD4+ T cell purification
For in vitro help assays, cells from spleens were depleted of
B cells, other MHC class II+ cells and CD8+ T cells to purify
CD4+ T cells. Following red blood cell lysis, cell preparations
were incubated with biotin-conjugated antibodies against
MHC class II (M5114, in-house), j light chain (187.1, in-
house), anti-IgM (Southern Biotechnology Associates) and
CD8 (53-6.72, in-house) for 15 min on ice. The cells were
washed and incubated with streptavidin-conjugated microbe-
ads (Miltenyi Biotech) and then purified on a varioMACS
magnet (Miltenyi Biotech) according to the manufacturer's
instructions.
Adoptive transfer of cells
Lymph node cells (popliteal, inguinal, brachial, axillary,
superficial cervical, periaortic, iliac and mesenteric) from
OT-II mice (ICOS–/– or wild type) were injected i.v. into
recipient mice, at 4  106–5  106 cells/mouse.
In vivo priming by DC
Mice were injected i.p. with 5  105 DC that had been cultured
for 18 h in the presence of SEA, Pa or medium alone. After
7 days, spleens were removed and 1  106 splenocytes plated
per well of a 96-well plate in X-vivo 15 serum-free medium
(Cambrex, Wokingham, UK) supplemented with 2 mM L-glu-
tamine (Gibco) and 50 lM 2-ME (Sigma). SEA was added to
give a final concentration of 25 lg/mL and Pa at 5 lg/mL.
Culture supernatants were taken at 72 h to assess their
cytokine content by ELISA.
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Flow cytometry
Routinely 10 000–20 000 events were acquired on a FACS-
Calibur flow cytometer running CellQuest software (BD
Biosciences), using a live cell gate set by forward and side
scatter characteristics. Analysis was performed with FlowJo
software (TreeStar). When target populations were small (e.g.
OT-II adoptive transfers, PE-specific B cells and tetramer+
T cells), at least 200 000 events were collected and analyzed.
The following antibodies were used: anti-Va2-PE (BD-Phar-
mingen), anti-Vb5-FITC (BD-Pharmingen), anti-CD44-biotin
(clone 142.5), anti-CD4-allophycocyanin (APC) (BD-Pharmin-
gen), anti-CD19-FITC (clone ID3) and anti-ICOS-biotin (BD-
Pharmingen). In some cases, a secondary reagent, streptavi-
din-PerCP (BD-Pharmingen), was used.
Mice were immunized i.p. with 100 lg alum-precipitated
PE. Spleens were harvested 2 wk following the immunization
and cells were stained with 10 lg/mL PE and FITC-labeled
anti-CD19 mAb ID3. By the addition of PE, we can detect the
PE-binding B cells when analyzed by flow cytometry [49]. PE+
cells were compared between groups as percentage of ID3+
cells. Background PE staining in un-immunized mice was
minimal.
Tetramer staining was done as follows: 1  106–2  106
erythrocyte-depleted spleen or lymph node cells were plated in
96-well round-bottomplates, washed in IMDM containing 10%
FCS, before the addition of PE-labeled MHC class II tetramers
diluted in IMDM + 10% FCS. MHC class II tetramers were
made and used as described [28]. The cells were incubated at
37C for 3 h with gentle agitation every 20–30 min before
additional antibodies were added: APC-labeled anti-CD4 (BD-
Pharmingen), R phycoerythrin (RPE)-Cy5-labeled anti-F4/80
(Serotec) and FITC-labeled anti-CD44 (142.5, in-house), and
incubated for 10–15 min at room temperature. Cells were
washed three times in FACS buffer (PBS with 2% FCS), and
propidium iodide (Pharmingen) was added prior to acquisi-
tion. Tetramer-positive cells were identified as CD4 positive,
F4/80 negative and propidium iodide negative that bound the
H19-Env MHC class II tetramer.
Immunohistochemistry and quantitative histology
Spleens were frozen in OCT embedding medium (BDH) in
cryomoulds (BDH) on dry ice and stored at –80C. Tissue
sections (5 lm) were cut, dried and fixed with acetone.
Sections were stained with Texas-red-labeled polyclonal goat
anti-mouse IgM (SouthernBiotech) and FITC-conjugated pea-
nut agglutinin (Vector Labs) to visualize the germinal centers.
B cell follicles were delineated in spleen tissue sections by
staining with anti-IgD antibody (mAb 1126c-biotin). T cells
were identified as Thy1+ cells (mAb T24-FITC). Slides were
viewed on an Olympus BX50 microscope under reflected light
fluorescence and images were captured using Openlab
imaging software (Improvision). The number of T cells within
the IgD+ area was counted. For each mouse in a group, 10–15
follicles were counted in this way. The number of follicular
T cells was expressed per follicular section. Follicular size was
assessed using Openlab software.
Helper T cell assay
B cells were purified from the spleens of C57BL/6 mice
immunized i.p. with alum-precipitated DNP-KLH and killed
B. pertussis. CD4+ T cells were purified from spleens of ICOS+
and ICOS–/– mice, immunized with OVA-alum and killed
B. pertussis. Purified B (106 cells) and T cells (5  105 cells)
were cultured in vitro in the presence of 10 lg/mL soluble
DNP-OVA. The medium containing the antigen was removed
2 days later and replaced with fresh medium. The culture
supernatant was harvested after 5 days and DNP-specific
immunoglobulin isotypes were measured by ELISA.
Measurement of antigen-specific immunoglobulins by
ELISA
Anti-DNP antibodies in the serum of immunized mice or in the
culture supernatants of help assays were measured by ELISA.
ELISA plates (Dynex Technologies Inc.) were coated with
50 lg/mL DNP-BSA. Doubling dilutions of serum or super-
natant were made and incubated for 2 h at room temperature.
Following washing in PBS/0.05% Tween-20, plates were
incubated with alkaline phosphatase (AP)-conjugated poly-
clonal goat anti-mouse IgM, IgG, IgG1, IgG2b, IgG2c and IgG3
(all from Southern Biotechnology Associates). Antibody
binding was detected by addition of PNPP substrate (South-
ernBiotech) to the washed plates and the OD at 405 nm was
measured using an ELISA reader (Labsystems). Titers were
calculated by plotting serum/supernatant dilution against OD,
and taking the half-maximal OD, compared to standard
positive serum.
Measurement of cytokine by ELISA
Maxisorb plates (96-well; NUNC) were coated overnight at 4C
with antibodies against IL-4, IL-5, IL-10, IL-13 and IFN-c
(Sigma-Aldrich). After blocking for 2 h with 10% FCS-PBS,
culture supernatant and recombinant cytokine standards
(Peprotech or Pharmingen) were added and incubated at
4C overnight. After washing, cytokine-specific biotin-con-
jugated antibodies were added (BD Pharmingen) for 1 h at
room temperature. Peroxidase-conjugated streptavidin was
then added followed by the substrate TMB. Absorbance was
measured at 450 nm and the amount of cytokine was
measured by interpolation from a standard curve.
Enumeration of antigen-specific ASC by ELISPOT
Nitrocellulose plates (96-well; Millipore) were coated with
DNP-BSA and blocked with 10% FCS-PBS. After washing,
spleen and bone marrow cell suspensions were added in
triplicate, over the range of 104–106 total cells per well.
Following overnight incubation at 37C, 5% CO2, plates were
washed thoroughly: three times with PBS, three times with
PBS/0.05% Tween-20, then three times again with PBS. The
secondary antibody, AP-conjugated goat anti-mouse IgM, IgG,
or IgG1 was added in PBS-5% BSA, 4 h at room temperature,
then washed. Spots were developed using 5-bromo 4-chlor-
ophosphate (BCIP; Sigma-Aldrich). Spots were scored by eye
using a dissectionmicroscope, and the average number of spots
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per well was used to calculate the frequency of DNP-specific
ASC. Spleen and bone marrow from non-immunized control
mice consistently gave no spots for IgG, although in one
experiment IgM spots were noticed in control mice.
Statistics
Statistics were calculated using GraphPad Prism version 3.0
(GraphPad software, San Diego, CA). Results were considered
significant if p <0.05. For some experiments (see figure
legends), data from several repeat experiments were pooled
and analyzed using an unpaired t-test, applying Welch's
correction where there were unequal variances.
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